Live Breaking News & Updates on Iopharma culture

Stay informed with the latest breaking news from Iopharma culture on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Iopharma culture and stay connected to the pulse of your community

Selkirk Pharma: Adapting to regulatory shifts and market demand

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.

Supply-chain , Digital-transformation-plan , Markets-amp-regulations , Io-developments , Iopharma-culture , Ipelines , Merging-markets , Mo , Ontract-manufacturing , Anufacturing , Upply-chain

Eli Lilly under pressure: Can it solve GLP-1 supply squeeze?

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act – fast.

Canada , India , Vietnam , Republic-of , David-ricks , Eli-lilly , Vikram-shanbhag , Nicolas-schmitz , Lilly-mounjaro , Lars-fruergaard , Novo-nordisk-wegovy , Novo-nordisk

Eli Lilly under pressure: Can they solve GLP-1 supply squeeze?

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act – fast.

Vietnam , Republic-of , Canada , India , Eli-lilly , Novo-nordisk-wegovy , Nicolas-schmitz , Novo-nordisk , Dave-knapp , Lars-fruergaard , Lilly-mounjaro , Vikram-shanbhag

Industry lauds Great Ormond Street's child gene therapy expansion

Great Ormond Street Hospital (GOSH) has announced its new plan to ‘revolutionise’ how children living with rare diseases can gain access to cutting-edge gene therapy.

United-kingdom , Lucy-jones , Xmoor-pharma , Lucy-foley , Opie-jones , Catriona-crombie , Aoife-regan , University-of-birmingham , Institute-of-child-health , Ormond-street-institute , Child-health , Severe-compromised-immuno-deficiency

Breakthrough UTI vaccine could prevent infections for nine years

Recurring urinary tract infections (UTIs) can be prevented for up to nine years with a simple oral spray vaccine, a ‘breakthrough’ British trial has shown.

Spain , Paris , France-general- , France , United-kingdom , Berkshire , United-kingdom-general- , Spanish , Jennifer-rohn , Bob-yang , European-association-of-urology , Royal-berkshire-hospital

Simple blood test could help detect Alzheimer's years earlier

Thousands of people across the UK will be offered a blood test to detect dementia, in a bid to revolutionize the country’s ‘shocking’ diagnosis rate.

United-kingdom , Fiona-carragher , Vanessa-raymond , Jonathan-schott , University-of-oxford , Oxford-university , Alzheimer-research-united-kingdom , University-college-london , Alzheimer-society , National-institute-for-health , Care-research , Blood-biomarker-challenge

Bringing CAR-T into the community: 'Healthcare is like politics – it's local'

Today, just two in ten patients have access to CAR-T therapy in the US. Considering this challenging landscape, the shift has focused from academic centers to community clinics, as they may be able to serve more patients.

Tennessee , United-states , Jeff-patton , Cindy-perettie , Tennessee-oncology , One-oncology , Markets-amp-regulations , Iopharma-culture , Ipelines , Merging-markets , Ell-amp-gene-therapies

GSK's Maya Martinez David: 'Trust is the most powerful thing in an organization'

“When you have people who like what they do and believe they’re having an impact, you can do anything – more than any project or investment. Prioritise your teams and people because they’re your biggest asset.”

Pennsylvania , United-states , Washington , Martinez-david , Maya-martinez-david , Pennsylvania-convention-center , Reuters-pharma-united-states , Bio-developments , Arkets-amp-regulations , Iopharma-culture , Ipelines , Ntibody-drug-conjugates

Novo Nordisk and Catalent deal: net positive or negative for industry?

Novo Nordisk recently acquired three manufacturing facilities from contract development and manufacturing organization Catalent, in a bold move that has sparked a great deal of debate and some backlash.

Maryland , United-states , Brussels , Bruxelles-capitale , Belgium , Indiana , Italy , Nicolas-schmitz , Catalent-bloomington , Lars-fruergaard , Eli-lilly , Gil-roth

Gilead Sciences 'strengthens commitment' to inflammatory disease with new research site

Gilead Sciences has celebrated the opening of its new research site at the Business Park in Oxford with a ribbon-cutting event.

United-kingdom , United-states , Lynne-murray , Flavius-martin , Anneliese-dodds , Oxford-university , Gilead-sciences , Oxford-at-gilead-sciences , Oxford-east , Bio-developments , Iopharma-culture , Ipelines